论文部分内容阅读
本文根据10000刨胃切除标本对进展期胃癌(AGC)和早期胃癌(EGC)的临床病理资料进行分析,以评价影响胃癌远期疗效的因素.方法:日本福冈九州大学医学院第二病理科1962～1989年连续登记的胃切除标本10000例,胃癌7031例,其中AGC3868例,EGC3163例.AGC肉眼分型为息肉型、溃疡局限型、溃疡浸润型、弥漫浸润型和未分型五型.EGC是指癌局限于粘膜(m)或粘膜下层(sm),不管有无淋巴结转移.切线癌阳性是指近、远端切缘5mm范围以内组织学查见癌.胃癌的随访率78%,中位随访时间56.8个月.
The purpose of this study was to analyze the clinicopathological data of advanced gastric cancer (AGC) and early gastric cancer (EGC) based on 10000 planogastric resection specimens to evaluate the factors affecting the long-term efficacy of gastric cancer. Methods: Second Department of Pathology, Faculty of Medicine, Kyushu University, Fukuoka, Japan, 1962 In 1989, 10,000 cases of consecutive gastrectomy specimens were registered, and 7031 cases of gastric cancer were detected, of which AGC was 3868 cases and EGC 3163 cases. AGC was classified as polypoid, ulcer-limited, ulcer-infiltrating, diffuse-infiltrating, and undifferentiated-type EGC. It means that the cancer is confined to the mucous membrane (m) or submucosa (sm), with or without lymph node metastasis. Positive tangential carcinoma refers to the histological examination of cancer within 5 mm of the proximal and distal margins. The follow-up rate of gastric cancer is 78%. Follow-up time was 56.8 months.